Correlation Between Altagas Cum and Oncolytics Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Altagas Cum and Oncolytics Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Altagas Cum and Oncolytics Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Altagas Cum Red and Oncolytics Biotech, you can compare the effects of market volatilities on Altagas Cum and Oncolytics Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Altagas Cum with a short position of Oncolytics Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Altagas Cum and Oncolytics Biotech.

Diversification Opportunities for Altagas Cum and Oncolytics Biotech

-0.41
  Correlation Coefficient

Very good diversification

The 3 months correlation between Altagas and Oncolytics is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Altagas Cum Red and Oncolytics Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oncolytics Biotech and Altagas Cum is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Altagas Cum Red are associated (or correlated) with Oncolytics Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oncolytics Biotech has no effect on the direction of Altagas Cum i.e., Altagas Cum and Oncolytics Biotech go up and down completely randomly.

Pair Corralation between Altagas Cum and Oncolytics Biotech

Assuming the 90 days trading horizon Altagas Cum Red is expected to generate 0.24 times more return on investment than Oncolytics Biotech. However, Altagas Cum Red is 4.21 times less risky than Oncolytics Biotech. It trades about 0.2 of its potential returns per unit of risk. Oncolytics Biotech is currently generating about -0.34 per unit of risk. If you would invest  1,855  in Altagas Cum Red on August 25, 2024 and sell it today you would earn a total of  64.00  from holding Altagas Cum Red or generate 3.45% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Altagas Cum Red  vs.  Oncolytics Biotech

 Performance 
       Timeline  
Altagas Cum Red 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Altagas Cum Red has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Altagas Cum is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.
Oncolytics Biotech 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Oncolytics Biotech are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating fundamental indicators, Oncolytics Biotech may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Altagas Cum and Oncolytics Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Altagas Cum and Oncolytics Biotech

The main advantage of trading using opposite Altagas Cum and Oncolytics Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Altagas Cum position performs unexpectedly, Oncolytics Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oncolytics Biotech will offset losses from the drop in Oncolytics Biotech's long position.
The idea behind Altagas Cum Red and Oncolytics Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Other Complementary Tools

Bonds Directory
Find actively traded corporate debentures issued by US companies
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like